Surgalign Holdings Performance
| SRGADelisted Stock | USD 0.01 0.00 0.00% |
The entity has a beta of -1.09, which indicates a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Surgalign Holdings are expected to decrease slowly. On the other hand, during market turmoil, Surgalign Holdings is expected to outperform it slightly. Surgalign Holdings right now has a risk of 0.0%. Please validate Surgalign Holdings skewness, as well as the relationship between the rate of daily change and market facilitation index , to decide if Surgalign Holdings will be following its existing price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Surgalign Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Surgalign Holdings is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 51.3 M |
Surgalign |
Surgalign Holdings Relative Risk vs. Return Landscape
If you would invest 1.10 in Surgalign Holdings on January 26, 2024 and sell it today you would earn a total of 0.00 from holding Surgalign Holdings or generate 0.0% return on investment over 90 days. Surgalign Holdings is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Surgalign, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Surgalign Holdings Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Surgalign Holdings' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Surgalign Holdings, and traders can use it to determine the average amount a Surgalign Holdings' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| SRGA |
Based on monthly moving average Surgalign Holdings is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Surgalign Holdings by adding Surgalign Holdings to a well-diversified portfolio.
Surgalign Holdings Fundamentals Growth
Surgalign Stock prices reflect investors' perceptions of the future prospects and financial health of Surgalign Holdings, and Surgalign Holdings fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Surgalign Stock performance.
| Return On Equity | -14.97 | |||
| Return On Asset | -0.35 | |||
| Profit Margin | (0.65) % | |||
| Operating Margin | (0.68) % | |||
| Current Valuation | (7.93 M) | |||
| Shares Outstanding | 9.18 M | |||
| Price To Book | 1.79 X | |||
| Price To Sales | 0.25 X | |||
| Revenue | 81.98 M | |||
| EBITDA | (68.28 M) | |||
| Cash And Equivalents | 29.34 M | |||
| Cash Per Share | 4.35 X | |||
| Total Debt | 10.19 M | |||
| Debt To Equity | 0.54 % | |||
| Book Value Per Share | (2.08) X | |||
| Cash Flow From Operations | (52.11 M) | |||
| Earnings Per Share | (8.12) X | |||
| Total Asset | 70.24 M | |||
| Retained Earnings | (624.22 M) | |||
About Surgalign Holdings Performance
To evaluate Surgalign Holdings Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Surgalign Holdings generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Surgalign Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Surgalign Holdings market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Surgalign's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois. Surgalign Hldg operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 231 people.Things to note about Surgalign Holdings performance evaluation
Checking the ongoing alerts about Surgalign Holdings for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Surgalign Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Surgalign Holdings is not yet fully synchronised with the market data | |
| Surgalign Holdings has some characteristics of a very speculative penny stock | |
| Surgalign Holdings has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 81.98 M. Net Loss for the year was (54.6 M) with profit before overhead, payroll, taxes, and interest of 40.29 M. | |
| Surgalign Holdings currently holds about 29.34 M in cash with (52.11 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.35, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 17.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Surgalign Holdings' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Surgalign Holdings' stock is overvalued or undervalued compared to its peers.
- Examining Surgalign Holdings' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Surgalign Holdings' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Surgalign Holdings' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Surgalign Holdings' stock. These opinions can provide insight into Surgalign Holdings' potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Surgalign Holdings information on this page should be used as a complementary analysis to other Surgalign Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Surgalign Stock
If you are still planning to invest in Surgalign Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Surgalign Holdings' history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |